<code id='C507BA2D44'></code><style id='C507BA2D44'></style>
    • <acronym id='C507BA2D44'></acronym>
      <center id='C507BA2D44'><center id='C507BA2D44'><tfoot id='C507BA2D44'></tfoot></center><abbr id='C507BA2D44'><dir id='C507BA2D44'><tfoot id='C507BA2D44'></tfoot><noframes id='C507BA2D44'>

    • <optgroup id='C507BA2D44'><strike id='C507BA2D44'><sup id='C507BA2D44'></sup></strike><code id='C507BA2D44'></code></optgroup>
        1. <b id='C507BA2D44'><label id='C507BA2D44'><select id='C507BA2D44'><dt id='C507BA2D44'><span id='C507BA2D44'></span></dt></select></label></b><u id='C507BA2D44'></u>
          <i id='C507BA2D44'><strike id='C507BA2D44'><tt id='C507BA2D44'><pre id='C507BA2D44'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:fashion    Page View:8788
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Lab trade group sues FDA to halt regulation of lab
          Lab trade group sues FDA to halt regulation of lab

          Thesuit,filedinaTexasfederalcourtbytheAmericanClinicalLaboratoryAssociationandPCRlabHealthTrackRx,cl

          read more
          After affirmative action ruling, medical educators look to 'holistic review'
          After affirmative action ruling, medical educators look to 'holistic review'

          AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

          read more

          FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

          AdobeExpertadviserstotheFoodandDrugAdministrationonFridayvotedunanimouslyinfavorof expandingtheappro